1. Medtech Insight
  2. >>Leadership
  3. >>Interviews

OneCell Diagnostics’ Mohan Uttarwar Discusses Liquid Biopsy Breakthroughs And The Future Of Precision Oncology

Firm Co-Founder Outlines How Science Meets Scale In Second Part Of The Interview

 
• By Shubham Singh

OneCell’s co-founder Uttarwar discusses clinical validation milestones, CLIA certification, and the startup’s strategic roadmap – from hospital partnerships in India to biopharma collaborations in the US.

As the company gears up for its presence at AACR 2025, this part of the discussion provides a revealing look at the intersection of science, startup execution, and the evolving business of cancer diagnostics.
Key Takeaways

· OneCell has received its CLIA certification in the US and is pursuing CAP and FDA 510(k) pathways, aiming to scale its lab-developed tests without delaying commercial traction.

· With partnerships across 20+ hospitals and hundreds of oncologists in India, OneCell is now targeting Southeast Asia and Africa, and building automated systems for broader reach.

· Backed by a globally trained team and strategic investors, the company is balancing deep scientific R&D with scalable operations and strategic biopharma collaborations.

In the second half of the Medtech Insight’s interview, Mohan Uttarwar, co-founder and CEO of OneCell Diagnostics, dive deeper into...

More from Interviews

Experts Call For Database Of Medical Device Labels

 
• By Elizabeth Orr

A recent JAMA column called for the US FDA to create an online database of medical device labeling, arguing that the move would increase transparency and help researchers, among other benefits. Medtech Insight discussed the idea with the paper’s lead author.

Digital Health Roundup: Autonomous Robots, Medtronic’s Surgeon School, Sleep & FDA Rules

 
• By Marion Webb, Brian Bossetta, Shubham Singh, and Natasha Barrow

In this week's Digital Health Roundup, Medtech Insight's team discusses progress on autonomous surgery, Medtronic's new partnership with IRCAD, FDA cybersecurity news, and C-suite interviews with OpenWater, Flow Neuroscience and EnsoData.

PFA Market Surges As UK NICE Opens Doors And US FDA Approves Boston, J&J Incremental Innovations

 
• By Natasha Barrow

The pulsed-field ablation market is surging, with the UK NHS opening doors and FDA updates for major players. Medtech Insight spoke with Steven Mickelsen, founder of Farapulse (the first clinically approved PFA system), about the sector's growth and his new venture, Field Medical.

Bivacor Rotary Heart Could Upend The Artificial Heart Market, If It Reaches Its Destination

 
• By Marion Webb

Bivacor aims to be first to the US market with a permanent total artificial heart, starting with use as a bridge to transplant. CMO William Cohn says data from countries with low transplant rates could support pivotal trials and long-term use.

More from Medtech Insight